Respiratory Infections

Respiratory Infections — Internal Medicine

How it begins

Guía exhaustiva de neumología infecciosa — microbiología clínica, fisiopatología, criterios diagnósticos, escalas de gravedad y protocolos antibióticos basados en guías vigentes.

What it covers

1. Introduction and Global Epidemiology
2. · 1.1 Global Burden and Magnitude of the Problem
3. · 1.2 Defense Mechanisms of the Respiratory System
4. Community Acquired Pneumonia (CAP)
5. · 2.1 Etiology and Microbiology
6. · 2.2 Clinical Diagnosis
7. · 2.3 Radiological and Laboratory Diagnosis
8. · 2.4 Severity Scales and Admission Decision
9. · 2.5 Antibiotic Treatment of CAP
10. · 2.6 Severe CAP — ICU Management and Complications
11. Nosocomial Pneumonia: HAP and VAP
12. · 3.1 Definitions and Epidemiology
13. · 3.2 Microbiology — Germs and Resistance
14. · 3.3 NAH / NAVM Empirical Treatment
15. Acute Bronchitis and Upper Airway Infections
16. · 4.1 Acute Bronchitis
17. · 4.2 Infectious Exacerbation of COPD (EAECOPD)
18. · 4.3 Upper Airway Infections
19. Pulmonary Tuberculosis
20. · 5.1 Pathogenesis — From Primary Infection to Active TB
21. · 5.2 Diagnosis of Tuberculosis
22. · 5.3 Treatment of Tuberculosis
23. Non-Tuberculous Mycobacteria (NTM)
24. Fungal Pulmonary Infections
25. · 7.1 Pulmonary Aspergillosis
26. · 7.2 Pneumocystis jirovecii (PCP)
27. · 7.3 Endemic Mycoses
28. Respiratory Viral Infections
29. · 8.1 Influenza (Flu)
30. · 8.2 COVID-19 — SARS-CoV-2
31. · 8.3 Respiratory Syncytial Virus (RSV) and Other Viruses
32. Lung Abscess and Pleural Empyema
33. · 9.1 Lung Abscess
34. · 9.2 Pleural Empyema
35. Respiratory Infections in the Immunocompromized Host
36. Bacterial Resistance and Future Perspectives
37. · 11.1 Bacterial Resistance Mechanisms
38. · 11.2 New Antibiotics Approved in Respiratory Infections (2015–2025)
39. · 11.3 Stewardship Strategies and Perspectives